Collaborate with NCATS Scientists (February 2016)

Bridging Interventional Development Gaps (BrIDGs)

Through its BrIDGs program, NCATS assists researchers in advancing promising therapeutic agents through late-stage pre-clinical development toward an Investigational New Drug application and clinical testing. NCATS is accepting proposals on an ongoing basis to collaborate with BrIDGs scientists. For more information, contact BrIDGs@mail.nih.gov.

NCATS Chemical Genomics Center (NCGC)

NCATS’ NCGC program staff offer biomedical researchers access to large-scale screening capacity and medicinal chemistry and informatics expertise to develop chemical probe molecules. These resources can help scientists study the functions of genes, cells and biochemical pathways. The program also features assay development and high-throughput screening, chemistry and chemistry technology, automation, and informatics. To learn more and to obtain NCGC probe molecules, contact Ajit Jadhav.

NIH RNA Interference (RNAi) Initiative

Through the NIH RNAi initiative, NCATS provides NIH intramural researchers with state-of-the-art, high-throughput RNAi genome-wide screens for humans and mice. Contact Anna Rossoshek to learn more.

Pfizer's Centers for Therapeutic Innovation (CTI) for NIH Researchers

NCATS is facilitating Pfizer's CTI program at NIH, which pairs NIH intramural researchers and clinicians with Pfizer resources to pursue scientific and medical advances through joint therapeutic development of biologic compounds. To apply, submit a completed pre-proposal brief to your NIH Institute or Center's technology transfer office by June 17, 2016. For more information, contact NIH-PfizerCTI@mail.nih.gov

Therapeutics for Rare and Neglected Diseases (TRND)

The TRND program provides collaborators with access to significant in-kind resources and expertise to develop new therapeutics for rare and neglected diseases. NCATS is accepting proposals on an ongoing basis through the TRND program for collaborative projects that focus on pre-clinical and early clinical development of new drugs for rare and neglected tropical diseases. Email TRND@mail.nih.gov to learn more.  

Toxicology in the 21st Century (Tox21)

The goal of the Tox21 program is to test 10,000 chemicals and evaluate their potential to cause health problems. Any investigator may propose the development of biological assays for high-throughput screening. Proposed assays must be compatible with the high-throughput screening guidelines described in the assay guidance criteria. To suggest an assay, submit a nomination form (PDF - 44KB) to Menghang Xia, Ph.D.

Collaborate on Other Intramural Projects

Explore other potential project collaborations with NCATS scientists by visiting the NIH Intramural Database and selecting “NCATS - National Center for Advancing Translational Sciences” in the “Select IC or Center” drop-down menu.